TP
IDXX icon

Truvvo Partners’s Idexx Laboratories IDXX Stock Holding History

Truvvo Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,295
Closed -$3.59M – 29
2018
Q4 		$3.59M Buy
19,295
+5,250
+37% +$1.08M 2.57% 10
2018
Q3 		$3.51M Sell
14,045
-221
-2% -$53.6K 2.18% 10
2018
Q2 		$3.11M Hold
14,266
– – 2.05% 11
2018
Q1 		$2.73M Sell
14,266
-802
-5% -$148K 1.01% 28
2017
Q4 		$2.36M Hold
15,068
– – 0.8% 32
2017
Q3 		$2.34M Sell
15,068
-32
-0.2% -$5.06K 0.78% 33
2017
Q2 		$2.44M Sell
15,100
-7,314
-33% -$1.19M 0.88% 31
2017
Q1 		$3.46M Sell
22,414
-3,053
-12% -$421K 1.55% 13
2016
Q4 		$2.99M Sell
25,467
-348
-1% -$39.7K 1.04% 19
2016
Q3 		$2.91M Sell
25,815
-1,975
-7% -$208K 1.31% 19
2016
Q2 		$2.58M Sell
27,790
-2,146
-7% -$184K 1.33% 20
2016
Q1 		$2.35M Sell
29,936
-2,792
-9% -$201K 1.06% 20
2015
Q4 		$2.39M Buy
+32,728
New +$2.33M 1.25% 20

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Truvvo Partners's IDXX Position: Q1 2019 in Review

Truvvo Partners sold out of Idexx Laboratories (IDXX) in Q1 2019, closing a stake of 19,295 shares — an estimated $3.59M sold.

Truvvo Partners first reported a position in IDXX in Q4 2015 and held it in 13 quarters. The position peaked at $3.59M in Q4 2018. 685 funds tracked by Wall St. Rank hold IDXX as of Q1 2019.

  • Truvvo Partners reported no remaining Idexx Laboratories position as of Q1 2019 after selling out during the quarter.
  • Truvvo Partners sold 19,295 Idexx Laboratories shares in Q1 2019, an estimated $3.59M.
  • Truvvo Partners first reported a position in Idexx Laboratories in Q4 2015 and held it in 13 quarters.
  • Truvvo Partners's Idexx Laboratories position peaked at $3.59M in Q4 2018.
  • 685 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2019.

Based on Truvvo Partners's 13F filing for Q1 2019, filed 15 May 2019.